Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2003
03/05/2003EP1286992A1 Piperidyindoles as serotonin receptor ligands
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
03/05/2003EP1286984A2 Method for the preparation of tetrahydrobenzothiepines
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
03/05/2003EP1286974A2 Medicament for viral diseases
03/05/2003EP1286973A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
03/05/2003EP1286972A1 Pyrimidine compounds
03/05/2003EP1286971A1 (e)-7[4-(4-fluorophenyl)-6-isopropyl-2-mesylaminopyrimidin-5-yl]-(3r,5s)-dihydroxyhept-6-enoic acid
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286964A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
03/05/2003EP1286957A1 Diphenylmethane derivatives
03/05/2003EP1286705A2 Bioconjugates of nanoparticles as radiopharmaceuticals
03/05/2003EP1286684A2 Cxcr4 antagonist treatment of hematopoietic cells
03/05/2003EP1286678A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer
03/05/2003EP1286674A1 Methods and compositions for potentiating cancer chemotherapeutic agents
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1286671A2 Compositions for the treatment of colorectal cancer comprising thalidomide and irinotecan
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP1286663A2 Encapsulating a toxic core within a non-toxic region in an oral dosage form
03/05/2003EP1286661A2 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
03/05/2003EP1286653A1 Composition containing at least one aryl oxime and at least one active substance for treating acne and the use thereof
03/05/2003EP1266661A9 Anticancer compositions
03/05/2003EP1202984B1 diphenyl-piperidine derivate
03/05/2003EP1169316B1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
03/05/2003EP1140923B1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
03/05/2003EP1131059B1 Dry powder for inhalation
03/05/2003EP1042278B1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
03/05/2003EP1003706B1 Cyclohexenone long-chain alcohol and medicament containing same
03/05/2003EP0966447B1 Small molecules useful in the treatment of inflammatory disease
03/05/2003EP0941088B1 Use of conjugated linoleic acid to enhance natural killer lymphocyte function
03/05/2003EP0939628B1 Thiol sulfone metalloprotease inhibitors
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0892633B1 Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation
03/05/2003EP0835262B1 Method for the treatment of corticosteroid induced osteopenia
03/05/2003EP0833626B1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders
03/05/2003EP0831830B1 Imidazole compounds
03/05/2003EP0801067B1 Novel quinuclidine derivatives and medicinal composition thereof
03/05/2003EP0791009A4 Modified neuropeptide y receptors
03/05/2003EP0754060B1 New combination of a beta-receptor blocker and a local anaesthetic
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0724457B1 Radiation sensitization using texaphyrins
03/05/2003EP0667784B1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
03/05/2003EP0554352B1 A method for transplanting cells into the brain and therapeutic uses therefor
03/05/2003CN1400976A Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates
03/05/2003CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
03/05/2003CN1400973A Novel biarylcarboxamides
03/05/2003CN1400970A Substituted arylpyrazines
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
03/05/2003CN1400909A Pharmaceutical composition
03/05/2003CN1400908A Combinations comprising dipeptidylpepidase IV inhibitors and antidiabetic agents
03/05/2003CN1400906A Treatment of congestive heart failure by pretreated autologous blood
03/05/2003CN1400904A Selective estrogen receptor modulators in combination with estrogens
03/05/2003CN1400903A Novel combination of non sedative anti histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjuncitivitis
03/05/2003CN1400899A Use of 2-methyl thiazolidin-2, 4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/05/2003CN1400896A Ibuprofen containing active agent preparation
03/05/2003CN1399965A Medicine for curing side effect resulted from chemical therapy and radiation therapy and its production method
03/05/2003CN1102596C 5H-thiazole [3,2-a] pyrmidine derivatives
03/05/2003CN1102595C Penems and their derivatives
03/05/2003CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/05/2003CN1102390C Fase dissolving galanthamine hydrobromide tablet
03/05/2003CA2421283A1 Novel mmp-2 derivatives for use as inhibitors of integrin .alpha.v.beta.3
03/05/2003CA2356438A1 Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers
03/04/2003US6528681 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
03/04/2003US6528677 Selective retinoid agonists
03/04/2003US6528676 Estrogenic compounds as anti-mitotic agents
03/04/2003US6528637 Fatty acid synthase mRNA binding protein
03/04/2003US6528619 Cyclic peptide binding inhibitors; structural formulas; use drugs for diseases mediated by urokinase and receptor; tumors; inflammation; angiogenesis
03/04/2003US6528540 Administering by injection
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
03/04/2003US6528526 Inhibition of cell proliferation and/or cell matrix production and/or cell movement (chemotaxis) and/or T cell activation and proliferation
03/04/2003US6528524 Treating the multiple drug resistance, arrhythmia, spasms and malaria; reacting hydrochloric acid with cinchonine or to cinchonine monohydrochloride in form cinchonine dihydrochloride; high purity
03/04/2003US6528523 N-acyl- or N-sulfonylpiperidine substituted tricyclic benzocycloheptenepyridine derivatives
03/04/2003US6528512 Cytokine specific binding protein;
03/04/2003US6528511 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
03/04/2003US6528509 Pyrazole compositions useful as inhibitors of ERK
03/04/2003US6528493 Modulating activity of endogenous protein
03/04/2003US6528315 Transfection of preferential nucleotide sequences into aggregations; mix sample and nucleotide sequences, incubate, expose to electric pulse, recover transformed aggregations
03/04/2003US6528312 Nuclease inhibitor (G-Actin) or interleukin-10 (IL-10) use improving cell transfection; mixtures; polynucleotides; use gene therapy, vaccines
03/04/2003US6528306 Engraftable human neural stem cells
03/04/2003US6528281 DNA encoding human interleukin-11 receptor
03/04/2003US6528245 Bone marrow cells as a source of neurons for brain and spinal cord repair
03/04/2003US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast
03/04/2003US6528040 EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
03/04/2003CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists
03/03/2003WO2002020496A1 2-guanidino-4-aryl-quinazoline
03/03/2003WO2002019971A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
03/03/2003CA2421222A1 2-guanidino-4-aryl-quinazoline
03/01/2003WO2003000027A2 Blocking peptide for inflammatory cell secretion
03/01/2003CA2452123A1 Blocking peptide for inflammatory cell secretion
02/2003
02/28/2003WO2002020009A1 Medicinal compositions
02/28/2003WO2002017913A1 Medicinal compositions for preventing or treating heart failure
02/28/2003CA2420951A1 Medicinal compositions
02/28/2003CA2420844A1 Medicinal compositions for preventing or treating heart failure
02/27/2003WO2003016917A2 Sodium channel regulators and modulators
02/27/2003WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof
02/27/2003WO2003016567A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
1 ... 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 ... 1564